Oragen
Oragen drugs are highly experimental nucleic acid technologies related to Ampligen, developed by HEMISPHERx Biopharma, Inc. It is hoped they will have antiviral effects. They are undergoing pre-clinical (in-vitro) trials.
Mechanism Of Action
It is believed that Oragen regulates the RNase L pathway and may also have effects specifically against the HIV virus.
External links
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.